Viewing StudyNCT05266105



Ignite Creation Date: 2024-05-06 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 2:26 PM
Study NCT ID: NCT05266105
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-06
First Post: 2022-02-11

Brief Title: A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HRHER2- Breast Cancer Patients
Sponsor:
Organization: Olema Pharmaceuticals Inc